Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
(Medrol (TN))		4件: Methylprednisolone (Depo-medrol 20 mg/ml),
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: Methylprednisolone (Medrol (TN)),
Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
2Administration of methylprednisolone, paracetamol and dexchlorpheniramine
(Medrol (TN))		3件: Acetaminophen,
Dexchlorpheniramine,
Methylprednisolone (Depo-medrol 20 mg/ml)		3件: Acetaminophen ,
Methylprednisolone (Medrol (TN)),
Dexchlorpheniramine 💬		4件: HRH1,
NR3C1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
3Administration of rituximab and methylprednisolone
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Rituximab		2件: Methylprednisolone (Medrol (TN)),
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51 💬
4Corticosteroid treatment (Methylprednisolone or prednisolone)
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Prednisolone		2件: Methylprednisolone (Medrol (TN)),
Prednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 64 💬
5Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(Medrol (TN))		4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone (Depo-medrol 20 mg/ml),
Prednisone		5件: Azathioprine ,
Cyclophosphamide ,
Methylprednisolone (Medrol (TN)),
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
6Depo Medrol----1件: 46 💬
7Depo-Medrol 40Mg/Ml Suspension for Injection----1件: 70 💬
8Infliximab, methylprednisolone, methotrexate
(Medrol (TN))		3件: Infliximab,
Methotrexate,
Methylprednisolone (Depo-medrol 20 mg/ml)		3件: Methotrexate ,
Methylprednisolone (Medrol (TN)),
Infliximab 💬		4件: DHFR,
DHFR2,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
9Interferon-beta-1a (Avonex) plus methylprednisolone
(Medrol (TN))		3件: Human interferon beta,
Interferon beta-1a,
Methylprednisolone (Depo-medrol 20 mg/ml)		2件: Methylprednisolone (Medrol (TN)),
Interferon beta-1a 💬		3件: IFNAR1,
IFNAR2,
NR3C1 💬		19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
10Intravenous (i.v.) methylprednisolone 1000 mg, total 9
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
11Intravenous Methylprednisolone
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 145 💬
12IV methylprednisolone
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
13IV methylprednisolone (steroids)
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
14Medrol1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 46, 56, 222 💬
15MEDROL - 4 MG COMPRESSE 30 COMPRESSE----1件: 56 💬
16Medrol 4 mg tablets1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
17Medrol A 16 mg tablets1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
18MEDROL*10CPR DIV 4MG1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
19Megadose oral methylprednisolone
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
20Methotrexate + Methylprednisolone
(Medrol (TN))		2件: Methotrexate,
Methylprednisolone (Depo-medrol 20 mg/ml)		2件: Methotrexate ,
Methylprednisolone (Medrol (TN)) 💬		3件: DHFR,
DHFR2,
NR3C1 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 46 💬
21Methylprednisolon (Solu-Medrol)1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
22Methylprednisolone
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
23Methylprednisolone (drug)
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
24Methylprednisolone (MP)
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 60, 285 💬
25Methylprednisolone (MP) or prednisone (pred)
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Prednisone		2件: Methylprednisolone (Medrol (TN)),
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
26Methylprednisolone (or other glucocorticoid)
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
27Methylprednisolone (Solu-Medrol)1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
28Methylprednisolone 1250 mg/24h x3 days
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
29METHYLPREDNISOLONE ACETATE
(Medrol (TN))		2件: Acetate,
Methylprednisolone (Depo-medrol 20 mg/ml)		1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 51 💬
30Methylprednisolone and azathioprine
(Medrol (TN))		2件: Azathioprine,
Methylprednisolone (Depo-medrol 20 mg/ml)		2件: Azathioprine ,
Methylprednisolone (Medrol (TN)) 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95 💬
31Methylprednisolone and Mycophenolate mofetil
(Medrol (TN))		3件: Methylprednisolone (Depo-medrol 20 mg/ml),
Mycophenolate mofetil,
Mycophenolic acid		3件: Methylprednisolone (Medrol (TN)),
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬2件: 93, 95 💬
32Methylprednisolone bolus IV 15 mg/kg/d for 3 days.
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
33Methylprednisolone hemisuccinate
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Methylprednisolone hemisuccinate (Solu-Medrol)		2件: Methylprednisolone (Medrol (TN)),
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
34Methylprednisolone IV
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
35METHYLPREDNISOLONE MYLAN Générique
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
36Methylprednisolone or budesonide
(Medrol (TN))		2件: Budesonide,
Methylprednisolone (Depo-medrol 20 mg/ml)		2件: Budesonide ,
Methylprednisolone (Medrol (TN)) 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
37Methylprednisolone or Prednisolone
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Prednisolone		2件: Methylprednisolone (Medrol (TN)),
Prednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
38Methylprednisolone PO
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
39Methylprednisolone pulse
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 66, 220 💬
40METHYLPREDNISOLONE SODIUM HEMISUCCINATE
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97 💬
41METHYLPREDNISOLONE SODIUM SUCCINATE
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Methylprednisolone hemisuccinate (Solu-Medrol)		2件: Methylprednisolone (Medrol (TN)),
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬6件: 13, 46, 49, 50, 51, 211 💬
42Methylprednisolone succinate
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Methylprednisolone hemisuccinate (Solu-Medrol)		2件: Methylprednisolone (Medrol (TN)),
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
43Methylprednisolone(intravenously in the 1st-2nd-3rd month )
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
44Methylprednisolone(intravenously in the 1st-3rd-5th month)
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
45Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
(Medrol (TN))		2件: Mesalazine,
Methylprednisolone (Depo-medrol 20 mg/ml)		2件: Mesalamine ,
Methylprednisolone (Medrol (TN)) 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
46Oral Methylprednisolone 625 mg/24h x3 days
(Medrol (TN))		1件: Methylprednisolone (Depo-medrol 20 mg/ml)1件: Methylprednisolone (Medrol (TN)) 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
47Prednisone (and methylprednisolone)
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Prednisone		2件: Methylprednisolone (Medrol (TN)),
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
48Prednisone, methylprednisolone,cyclophosphamides
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Prednisone		2件: Methylprednisolone (Medrol (TN)),
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
49SOLU MEDROL----1件: 56 💬
50SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53 💬
51SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML----1件: 56 💬
52SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML----1件: 56 💬
53Solu-Medrol2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Methylprednisolone hemisuccinate (Solu-Medrol)		2件: Methylprednisolone (Medrol (TN)),
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 13, 49, 50, 51, 53, 97, 211 💬
54Solu-medrol inj. PSO LQF 40mg1件: Methylprednisolone hemisuccinate (Solu-Medrol)1件: Methylprednisolone hemisuccinate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 50 💬
55Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)
(Medrol (TN))		2件: Methylprednisolone (Depo-medrol 20 mg/ml),
Ursodeoxycholic acid		2件: Methylprednisolone (Medrol (TN)),
Ursodiol 💬		2件: NR1H4,
NR3C1 💬		2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93 💬